ADPT
Price
$11.80
Change
+$0.32 (+2.79%)
Updated
Jul 3 closing price
Capitalization
1.79B
24 days until earnings call
CARM
Price
$0.40
Change
-$0.02 (-4.76%)
Updated
Jul 3 closing price
Capitalization
16.84M
Interact to see
Advertisement

ADPT vs CARM

Header iconADPT vs CARM Comparison
Open Charts ADPT vs CARMBanner chart's image
Adaptive Biotechnologies
Price$11.80
Change+$0.32 (+2.79%)
Volume$1.02M
Capitalization1.79B
Carisma Therapeutics
Price$0.40
Change-$0.02 (-4.76%)
Volume$398.66K
Capitalization16.84M
ADPT vs CARM Comparison Chart in %
Loading...
ADPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CARM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADPT vs. CARM commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADPT is a Hold and CARM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (ADPT: $11.80 vs. CARM: $0.40)
Brand notoriety: ADPT: Notable vs. CARM: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADPT: 44% vs. CARM: 2%
Market capitalization -- ADPT: $1.79B vs. CARM: $16.84M
ADPT [@Biotechnology] is valued at $1.79B. CARM’s [@Biotechnology] market capitalization is $16.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADPT’s FA Score shows that 0 FA rating(s) are green whileCARM’s FA Score has 0 green FA rating(s).

  • ADPT’s FA Score: 0 green, 5 red.
  • CARM’s FA Score: 0 green, 5 red.
According to our system of comparison, ADPT is a better buy in the long-term than CARM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADPT’s TA Score shows that 4 TA indicator(s) are bullish while CARM’s TA Score has 5 bullish TA indicator(s).

  • ADPT’s TA Score: 4 bullish, 4 bearish.
  • CARM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ADPT and CARM are a good buy in the short-term.

Price Growth

ADPT (@Biotechnology) experienced а -2.96% price change this week, while CARM (@Biotechnology) price change was -0.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ADPT is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADPT($1.79B) has a higher market cap than CARM($16.8M). ADPT YTD gains are higher at: 96.831 vs. CARM (-3.773). CARM has higher annual earnings (EBITDA): -49.68M vs. ADPT (-111.63M). ADPT has more cash in the bank: 193M vs. CARM (7.74M). CARM has less debt than ADPT: CARM (2.33M) vs ADPT (86.9M). ADPT has higher revenues than CARM: ADPT (190M) vs CARM (20M).
ADPTCARMADPT / CARM
Capitalization1.79B16.8M10,673%
EBITDA-111.63M-49.68M225%
Gain YTD96.831-3.773-2,567%
P/E RatioN/AN/A-
Revenue190M20M950%
Total Cash193M7.74M2,494%
Total Debt86.9M2.33M3,738%
FUNDAMENTALS RATINGS
ADPT vs CARM: Fundamental Ratings
ADPT
CARM
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
93
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
3535
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ADPT's Valuation (63) in the Hospital Or Nursing Management industry is in the same range as CARM (93) in the null industry. This means that ADPT’s stock grew similarly to CARM’s over the last 12 months.

ADPT's Profit vs Risk Rating (100) in the Hospital Or Nursing Management industry is in the same range as CARM (100) in the null industry. This means that ADPT’s stock grew similarly to CARM’s over the last 12 months.

ADPT's SMR Rating (97) in the Hospital Or Nursing Management industry is in the same range as CARM (100) in the null industry. This means that ADPT’s stock grew similarly to CARM’s over the last 12 months.

ADPT's Price Growth Rating (35) in the Hospital Or Nursing Management industry is in the same range as CARM (35) in the null industry. This means that ADPT’s stock grew similarly to CARM’s over the last 12 months.

ADPT's P/E Growth Rating (100) in the Hospital Or Nursing Management industry is in the same range as CARM (100) in the null industry. This means that ADPT’s stock grew similarly to CARM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADPTCARM
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bullish Trend 7 days ago
85%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ADPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CARM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGQLX17.400.16
+0.93%
Morgan Stanley Inst Global Stars L
SSSFX24.620.18
+0.74%
SouthernSun Small Cap, N
HRTVX50.730.34
+0.67%
Heartland Value Investor
IEIFX10.960.05
+0.46%
Invesco Equity and Income R6
BGIFX15.420.03
+0.22%
Baillie Gifford International Alpha 3

ADPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADPT has been loosely correlated with BEAM. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ADPT jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADPT
1D Price
Change %
ADPT100%
+2.79%
BEAM - ADPT
50%
Loosely correlated
+0.65%
TECH - ADPT
49%
Loosely correlated
-0.08%
ABSI - ADPT
46%
Loosely correlated
+2.97%
DNLI - ADPT
45%
Loosely correlated
-1.41%
CRBU - ADPT
45%
Loosely correlated
N/A
More

CARM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CARM has been loosely correlated with EVGN. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CARM jumps, then EVGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CARM
1D Price
Change %
CARM100%
-4.05%
EVGN - CARM
58%
Loosely correlated
-1.47%
INSM - CARM
40%
Loosely correlated
-0.45%
PMVP - CARM
33%
Loosely correlated
+8.18%
ABCL - CARM
31%
Poorly correlated
+1.33%
ADPT - CARM
31%
Poorly correlated
+2.79%
More